Tandem Diabetes Care Inc (TNDM)
47.30
+0.38
(+0.80%)
USD |
NASDAQ |
May 17, 16:00
47.30
0.00 (0.00%)
Pre-Market: 20:00
Tandem Diabetes Care Cash from Operations (Quarterly): -7.996M for March 31, 2024
Cash from Operations (Quarterly) Chart
Historical Cash from Operations (Quarterly) Data
Date | Value |
---|---|
March 31, 2024 | -7.996M |
December 31, 2023 | -7.216M |
September 30, 2023 | 0.055M |
June 30, 2023 | -6.323M |
March 31, 2023 | -18.33M |
December 31, 2022 | 5.82M |
September 30, 2022 | 23.94M |
June 30, 2022 | 6.901M |
March 31, 2022 | 13.80M |
December 31, 2021 | 19.64M |
September 30, 2021 | 34.14M |
June 30, 2021 | 28.90M |
March 31, 2021 | 28.68M |
December 31, 2020 | 15.24M |
September 30, 2020 | 14.56M |
June 30, 2020 | 15.50M |
March 31, 2020 | -20.63M |
December 31, 2019 | 19.44M |
September 30, 2019 | 23.02M |
June 30, 2019 | 3.568M |
March 31, 2019 | -4.124M |
December 31, 2018 | 14.13M |
September 30, 2018 | -3.457M |
Date | Value |
---|---|
June 30, 2018 | -6.723M |
March 31, 2018 | -12.27M |
December 31, 2017 | -11.64M |
September 30, 2017 | -19.02M |
June 30, 2017 | -14.66M |
March 31, 2017 | -20.81M |
December 31, 2016 | -13.58M |
September 30, 2016 | -18.15M |
June 30, 2016 | -13.49M |
March 31, 2016 | -15.94M |
December 31, 2015 | -10.25M |
September 30, 2015 | -14.34M |
June 30, 2015 | -18.76M |
March 31, 2015 | -15.42M |
December 31, 2014 | -13.54M |
September 30, 2014 | -13.58M |
June 30, 2014 | -17.30M |
March 31, 2014 | -16.96M |
December 31, 2013 | -12.83M |
September 30, 2013 | -10.96M |
June 30, 2013 | -15.17M |
March 31, 2013 | -8.811M |
Cash From Operations Definition
Cash flow from operations is a major line item of the statement of cash flows. This metric tracks the movement of cash flows for the overall operating activities of the company. A few examples of operating activities include change in receivables, change in inventories, and changes in current assets.
Cash from Operations (Quarterly) Range, Past 5 Years
-20.63M
Minimum
Mar 2020
34.14M
Maximum
Sep 2021
9.636M
Average
14.18M
Median
Cash from Operations (Quarterly) Benchmarks
Insulet Corp | 87.60M |
Abbott Laboratories | 1.025B |
Stryker Corp | 204.00M |
Twist Bioscience Corp | -19.42M |
Perspective Therapeutics Inc | 13.85M |
Cash from Operations (Quarterly) Related Metrics
Cash from Investing (Quarterly) | -5.056M |
Cash from Financing (Quarterly) | 13.59M |
Free Cash Flow | -66.71M |
Free Cash Flow Per Share (Quarterly) | -0.1906 |
Free Cash Flow to Equity (Quarterly) | -74.92M |
Free Cash Flow to Firm (Quarterly) | -12.45M |
Free Cash Flow Yield | -2.16% |